Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors: Highlights from the "2013 ASCO gastrointestinal cancers symposium". San Francisco, CA, USA. january 24-26, 2013

Ryan Stevenson, Steven Libutti, Muhammad Wasif Saif

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Neuroendocrine tumors (NET) are a diverse group of tumors that derive from epithelial cells with neuroendocrine differentiation. Gastroenteropancreatic NETs are a subset of NET that arise from the gastrointestinal tract. The natural history and prognosis varies widely between different gastroenteropancreatic NETs, highlighting the importance of identifying accurate prognostic and predictive biomarkers. At the 2013 ASCO Gastrointestinal Cancers Symposium, De Braud et al. (Abstract #186) and Bellister et al. (Abstract #163) present data on two new possible biomarkers.

Original languageEnglish (US)
Pages (from-to)155-157
Number of pages3
JournalJournal of the Pancreas
Volume14
Issue number2
StatePublished - Mar 1 2013

Fingerprint

Gastrointestinal Neoplasms
San Francisco
Neuroendocrine Tumors
Biomarkers
Natural History
Gastrointestinal Tract
Epithelial Cells
Neoplasms
Gastro-enteropancreatic neuroendocrine tumor

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Keywords

  • Biological markers
  • Gastro-enteropancreatic neuroendocrine tumors
  • Human
  • PHLPP2 protein
  • Succinate dehydrogenase

Cite this

@article{86cbc6b868534bcf98aec3403109f775,
title = "Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors: Highlights from the {"}2013 ASCO gastrointestinal cancers symposium{"}. San Francisco, CA, USA. january 24-26, 2013",
abstract = "Neuroendocrine tumors (NET) are a diverse group of tumors that derive from epithelial cells with neuroendocrine differentiation. Gastroenteropancreatic NETs are a subset of NET that arise from the gastrointestinal tract. The natural history and prognosis varies widely between different gastroenteropancreatic NETs, highlighting the importance of identifying accurate prognostic and predictive biomarkers. At the 2013 ASCO Gastrointestinal Cancers Symposium, De Braud et al. (Abstract #186) and Bellister et al. (Abstract #163) present data on two new possible biomarkers.",
keywords = "Biological markers, Gastro-enteropancreatic neuroendocrine tumors, Human, PHLPP2 protein, Succinate dehydrogenase",
author = "Ryan Stevenson and Steven Libutti and Saif, {Muhammad Wasif}",
year = "2013",
month = "3",
day = "1",
language = "English (US)",
volume = "14",
pages = "155--157",
journal = "Journal of the Pancreas",
issn = "1590-8577",
publisher = "E.S. Burioni Ricerche Bibliografiche",
number = "2",

}

TY - JOUR

T1 - Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors

T2 - Highlights from the "2013 ASCO gastrointestinal cancers symposium". San Francisco, CA, USA. january 24-26, 2013

AU - Stevenson, Ryan

AU - Libutti, Steven

AU - Saif, Muhammad Wasif

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Neuroendocrine tumors (NET) are a diverse group of tumors that derive from epithelial cells with neuroendocrine differentiation. Gastroenteropancreatic NETs are a subset of NET that arise from the gastrointestinal tract. The natural history and prognosis varies widely between different gastroenteropancreatic NETs, highlighting the importance of identifying accurate prognostic and predictive biomarkers. At the 2013 ASCO Gastrointestinal Cancers Symposium, De Braud et al. (Abstract #186) and Bellister et al. (Abstract #163) present data on two new possible biomarkers.

AB - Neuroendocrine tumors (NET) are a diverse group of tumors that derive from epithelial cells with neuroendocrine differentiation. Gastroenteropancreatic NETs are a subset of NET that arise from the gastrointestinal tract. The natural history and prognosis varies widely between different gastroenteropancreatic NETs, highlighting the importance of identifying accurate prognostic and predictive biomarkers. At the 2013 ASCO Gastrointestinal Cancers Symposium, De Braud et al. (Abstract #186) and Bellister et al. (Abstract #163) present data on two new possible biomarkers.

KW - Biological markers

KW - Gastro-enteropancreatic neuroendocrine tumors

KW - Human

KW - PHLPP2 protein

KW - Succinate dehydrogenase

UR - http://www.scopus.com/inward/record.url?scp=84875043116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875043116&partnerID=8YFLogxK

M3 - Article

C2 - 23474561

AN - SCOPUS:84875043116

VL - 14

SP - 155

EP - 157

JO - Journal of the Pancreas

JF - Journal of the Pancreas

SN - 1590-8577

IS - 2

ER -